{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2015-N-0002\" sorted by posted_date descending", "rows": [["FDA-2015-N-0002-0070", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Changes of\nSponsorship", "Rule", "Correction", "2016-04-01T04:00:00Z", 2016, 4, "2016-04-01T04:00:00Z", null, "2016-04-01T14:05:18Z", "C1-2016-07135", 0, 0, "0900006481f0947b"], ["FDA-2015-N-0002-0069", "FDA", "FDA-2015-N-0002", "FONSI for sN 141-361, approved December 7, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:15:00Z", null, 0, 0, "0900006481ee9519"], ["FDA-2015-N-0002-0067", "FDA", "FDA-2015-N-0002", "FOI Summary for sN 141-361, approved December 7, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:14:37Z", null, 0, 0, "0900006481ee9517"], ["FDA-2015-N-0002-0063", "FDA", "FDA-2015-N-0002", "EA for oN 141-453, approved December 8, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:13:05Z", null, 0, 0, "0900006481ee8c48"], ["FDA-2015-N-0002-0062", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Changes of\nSponsorship", "Rule", "Final Rule", "2016-03-30T04:00:00Z", 2016, 3, "2016-03-30T04:00:00Z", null, "2016-03-30T20:48:32Z", "2016-07135", 0, 0, "0900006481eea5dc"], ["FDA-2015-N-0002-0066", "FDA", "FDA-2015-N-0002", "FOI Summary for sN 141-258, approved December 2, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:14:24Z", null, 0, 0, "0900006481ee9516"], ["FDA-2015-N-0002-0068", "FDA", "FDA-2015-N-0002", "FONSI for  oN 141-453, approved December 8, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:14:49Z", null, 0, 0, "0900006481ee9518"], ["FDA-2015-N-0002-0064", "FDA", "FDA-2015-N-0002", "EA for sN 141-361, approved December 7, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:13:53Z", null, 0, 0, "0900006481ee8c49"], ["FDA-2015-N-0002-0065", "FDA", "FDA-2015-N-0002", "FOI Summary for oN 141-453, approved December 8, 2015", "Supporting & Related Material", "Background Material", "2016-03-30T04:00:00Z", 2016, 3, null, null, "2016-03-31T13:14:12Z", null, 0, 0, "0900006481ee9515"], ["FDA-2015-N-0002-0060", "FDA", "FDA-2015-N-0002", "Conditional Approval of a New Animal Drug No Longer in Effect; Masitinib", "Rule", "Final Rule", "2016-01-21T05:00:00Z", 2016, 1, "2016-01-21T05:00:00Z", null, "2016-01-21T16:13:22Z", "2016-01100", 0, 0, "0900006481e24805"], ["FDA-2015-N-0002-0061", "FDA", "FDA-2015-N-0002", "Conditional Approval of a New Animal Drug No Longer In Effect: Masitinib Mesylate Tablets", "Notice", "Notice of Termination", "2016-01-21T05:00:00Z", 2016, 1, "2016-01-21T05:00:00Z", null, "2016-01-21T16:31:41Z", "2016-01104", 0, 0, "0900006481e2489d"], ["FDA-2015-N-0002-0059", "FDA", "FDA-2015-N-0002", "New Animal Drugs for Use in Animal Feeds; Bacitracin Methylenedisalicylate", "Rule", "Final Rule", "2015-12-22T05:00:00Z", 2015, 12, "2015-12-22T05:00:00Z", null, "2015-12-22T14:25:51Z", "2015-32000", 0, 0, "0900006481dc12f6"], ["FDA-2015-N-0002-0057", "FDA", "FDA-2015-N-0002", "New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of New\nAnimal Drug Applications; Nitarsone", "Rule", "Withdrawal", "2015-12-18T05:00:00Z", 2015, 12, "2015-12-18T05:00:00Z", null, "2015-12-18T14:31:28Z", "2015-31828", 0, 0, "0900006481db9730"], ["FDA-2015-N-0002-0058", "FDA", "FDA-2015-N-0002", "New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of New\nAnimal Drug Applications; Nitarsone", "Rule", "Final Rule", "2015-12-18T05:00:00Z", 2015, 12, "2015-12-18T05:00:00Z", null, "2015-12-18T14:34:22Z", "2015-31827", 0, 0, "0900006481db988a"], ["FDA-2015-N-0002-0050", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications;\nWithdrawals of Approval of New Animal Drug Applications; Changes of\nSponsorship", "Rule", "Final Rule", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", null, "2015-12-09T15:36:21Z", "2015-31042", 0, 0, "0900006481d9202e"], ["FDA-2015-N-0002-0051", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Withdrawal of Approval of New Animal Drug\nApplications", "Rule", "Withdrawal", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", null, "2015-12-09T15:39:22Z", "2015-31040", 0, 0, "0900006481d92512"], ["FDA-2015-N-0002-0053", "FDA", "FDA-2015-N-0002", "Environmental Assessment Safe-Guard Aquasol for Chicken\n(20% Fenbendazole Suspension", "Supporting & Related Material", "Background Material", "2015-12-09T05:00:00Z", 2015, 12, null, null, "2015-12-09T15:53:03Z", null, 0, 0, "0900006481d92b7b"], ["FDA-2015-N-0002-0054", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-449 SAFE-GUARD AquaSol Fenbendazole oral suspension Broiler chickens, replacement chickens intended to become breeding chickens, and breeding chickens", "Supporting & Related Material", "Freedom of Information Summary", "2015-12-09T05:00:00Z", 2015, 12, null, null, "2015-12-09T15:55:42Z", null, 0, 0, "0900006481d92b7d"], ["FDA-2015-N-0002-0056", "FDA", "FDA-2015-N-0002", "Finding of No Significant Impact (FONSI) for SAFE-GUARD AQUASOL\n(fenbendazole oral suspension) in\nChickens", "Supporting & Related Material", "Background Material", "2015-12-09T05:00:00Z", 2015, 12, null, null, "2015-12-09T16:03:27Z", null, 0, 0, "0900006481d92bb3"], ["FDA-2015-N-0002-0052", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-440 CLARO Florfenicol, terbinafine, mometasone furoate otic solution Dog", "Supporting & Related Material", "Freedom of Information Summary", "2015-12-09T05:00:00Z", 2015, 12, null, null, "2015-12-09T15:47:16Z", null, 0, 0, "0900006481d92b7c"], ["FDA-2015-N-0002-0055", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY  NADA 141-442 LUTALYSE HighCon Injection Dinoprost Tromethamine Injection Lactating dairy cows, beef cows, beef heifers, and replacement dairy heifers", "Supporting & Related Material", "Freedom of Information Summary", "2015-12-09T05:00:00Z", 2015, 12, null, null, "2015-12-09T15:58:53Z", null, 0, 0, "0900006481d92bb2"], ["FDA-2015-N-0002-0049", "FDA", "FDA-2015-N-0002", "FINDING OF NO SIGNIFICANT IMPACT AquAdvantage Salmon In support of an approval of a New Animal Drug Application related to AquAdvantage Salmon, which are triploid, hemizygous, all-female Atlantic salmon (Salmo salar) bearing a single copy of the \u03b1-form of the opAFP-GHc2 recombinant DNA construct at the \u03b1-locus in the EO-1\u03b1 lineage", "Supporting & Related Material", "Background Material", "2015-12-07T05:00:00Z", 2015, 12, null, null, "2015-12-07T16:12:31Z", null, 0, 0, "0900006481d8a198"], ["FDA-2015-N-0002-0047", "FDA", "FDA-2015-N-0002", "AquAdvantage Salmon Environmental Assessment - In support of an approval of a New Animal Drug Application related to AquAdvantage Salmon which are Triploid, Hemizygous, all - female Atlantic salmon (Salmo Salar) bearing a single copy of the a-form of the opAFP-GHc2 recombinant DNA construct at the a-locus in the EO-1a lineage", "Supporting & Related Material", "Background Material", "2015-12-07T05:00:00Z", 2015, 12, null, null, "2015-12-07T16:04:22Z", null, 0, 0, "0900006481d89dac"], ["FDA-2015-N-0002-0048", "FDA", "FDA-2015-N-0002", "Freedom of Information Summary NADA 141-454 opAFP-GHc2 rDNA construct in EO-1a lineage Atlantic Salmon (AquAdvantage Salmon)", "Supporting & Related Material", "Background Material", "2015-12-07T05:00:00Z", 2015, 12, null, null, "2015-12-07T16:12:22Z", null, 0, 0, "0900006481d8a194"], ["FDA-2015-N-0002-0046", "FDA", "FDA-2015-N-0002", "New Animal Drugs in Genetically Engineered Animals; opAFP\u2013GHc2\nRecombinant Deoxyribonucleic Acid Construct", "Rule", "Final Rule", "2015-11-24T05:00:00Z", 2015, 11, "2015-11-24T05:00:00Z", null, "2015-11-24T17:08:38Z", "2015-29902", 0, 0, "0900006481d6d2ae"], ["FDA-2015-N-0002-0039", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-438\nKAVAULT Avilamycin Type A Medicated Article Swine", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:08Z", null, 0, 0, "0900006481cc5629"], ["FDA-2015-N-0002-0041", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY  NADA 141-443\nONSIOR (robenacoxib) injection cats", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:20Z", null, 0, 0, "0900006481cc59d1"], ["FDA-2015-N-0002-0031", "FDA", "FDA-2015-N-0002", "Elanco Animal Health A Division of Eli Lilly and Company\n2500 Innovation Way", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:06Z", null, 0, 0, "0900006481cc5621"], ["FDA-2015-N-0002-0032", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-553 Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, USP Neomycin and polymyxin B sulfates, and bacitracin zinc Ointment Dogs and cats\nFor the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:24Z", null, 0, 0, "0900006481cc5622"], ["FDA-2015-N-0002-0035", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-583\nACTOGAIN 45 plus RUMENSIN plus TYLOVET 100 plus MGA\nRactopamine Hydrochloride plus Monensin USP plus Tylosin Phosphate plus Melengestrol Acetate Type A Medicated Articles for Use in the Manufacture of Type C Medicated Feeds", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:44Z", null, 0, 0, "0900006481cc5625"], ["FDA-2015-N-0002-0037", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-585\nACTOGAIN 45 plus RUMENSIN plus TYLOVET 100 Ractopamine Hydrochloride plus Monensin USP plus Tylosin Phosphate\nType A Medicated Articles for Use in the Manufacture of Type B and Type C Medicated Feeds Cattle Fed in Confinement for Slaughter", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:56Z", null, 0, 0, "0900006481cc5627"], ["FDA-2015-N-0002-0045", "FDA", "FDA-2015-N-0002", "Finding of No Significant Impact (FONSI) for KAVAULT (avilamycin)\nType A Medicated Article For the reduction in incidence and overall severity of diarrhea in the presence of pathogenic Escherichia coli\nin Groups of Weaned Pigs Elanco Animal Health Greenfield, IN", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:41Z", null, 0, 0, "0900006481cc59d5"], ["FDA-2015-N-0002-0034", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-582\nLONCOR 300 Florfenicol Injectable Solution Beef and Non-lactating Dairy Cattle", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:37Z", null, 0, 0, "0900006481cc5624"], ["FDA-2015-N-0002-0036", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-584\nENGAIN plus TYLOVET 100 Ractopamine Hydrochloride plus Tylosin Phosphate Type A Medicated Articles for Use in the Manufacture of Type B and Type C Medicated Feeds Finishing Swine", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:50Z", null, 0, 0, "0900006481cc5626"], ["FDA-2015-N-0002-0040", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-442\nLUTALYSE HighCon Injection Dinoprost tromethamine injection\nLactating dairy cows, beef cows, beef heifers, and replacement dairy heifers", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:13Z", null, 0, 0, "0900006481cc59d0"], ["FDA-2015-N-0002-0029", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of a New Animal Drug Application; Change of Sponsor; Change of Sponsor\u2019s Address", "Rule", "Final Rule", "2015-10-13T04:00:00Z", 2015, 10, "2015-10-13T04:00:00Z", null, "2015-10-13T15:04:00Z", "2015-25918", 0, 0, "0900006481cc437c"], ["FDA-2015-N-0002-0043", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-509\nTILMOVET 90 Tilmicosin Type A medicated article Beef and Non-Lactating Dairy Cattle", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:30Z", null, 0, 0, "0900006481cc59d3"], ["FDA-2015-N-0002-0030", "FDA", "FDA-2015-N-0002", "New Animal Drugs for Use in Animal Feed; Withdrawal of Approval of a New Animal Drug Application; Penicillin G Procaine", "Rule", "Withdrawal", "2015-10-13T04:00:00Z", 2015, 10, "2015-10-13T04:00:00Z", null, "2015-10-13T15:12:02Z", "2015-25919", 0, 0, "0900006481cc492e"], ["FDA-2015-N-0002-0033", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-565 Thiabendazole, Dexamethasone, Neomycin Sulfate Solution Dogs and cats", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:48:30Z", null, 0, 0, "0900006481cc5623"], ["FDA-2015-N-0002-0038", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-591\nNORFENICOL Florfenicol Injectable Solution", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:02Z", null, 0, 0, "0900006481cc5628"], ["FDA-2015-N-0002-0042", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-495 ENROFLOX 100 Enrofloxacin injectable solution Beef and non-lactating dairy cattle", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:25Z", null, 0, 0, "0900006481cc59d2"], ["FDA-2015-N-0002-0044", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-216 QUEST PLUS Gel\nMoxidectin and praziquantel Oral Gel Horses", "Supporting & Related Material", "Background Material", "2015-10-13T04:00:00Z", 2015, 10, null, null, "2015-10-13T20:49:35Z", null, 0, 0, "0900006481cc59d4"], ["FDA-2015-N-0002-0026", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-282 ZILMAX plus RUMENSIN plus MGA\nZilpaterol Hydrochloride; Monensin, USP; and Melengestrol Acetate", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:12:04Z", null, 0, 0, "0900006481c563a8"], ["FDA-2015-N-0002-0020", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications", "Rule", "Correction", "2015-09-04T04:00:00Z", 2015, 9, "2015-09-04T04:00:00Z", null, "2015-09-04T14:05:27Z", "2015-21905", 0, 0, "0900006481c570fe"], ["FDA-2015-N-0002-0023", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA 141-417 CORAXIS Moxidectin Solution Dogs", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:10:17Z", null, 0, 0, "0900006481c563a5"], ["FDA-2015-N-0002-0024", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-188 MARQUIS (ponazuril) Oral Paste\nHorses", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:10:50Z", null, 0, 0, "0900006481c563a6"], ["FDA-2015-N-0002-0025", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-262 CERENIA Maropitant Citrate Tablets\nDogs", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:11:21Z", null, 0, 0, "0900006481c563a7"], ["FDA-2015-N-0002-0027", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION  NADA 141-284 ZILMAX plus MGA", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:12:31Z", null, 0, 0, "0900006481c563a9"], ["FDA-2015-N-0002-0028", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-278 ZILMAX plus RUMENSIN", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:13:27Z", null, 0, 0, "0900006481c563aa"], ["FDA-2015-N-0002-0021", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-497 LOXICOM Meloxicam\nOral Suspension Dogs", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:08:59Z", null, 0, 0, "0900006481c55f0b"], ["FDA-2015-N-0002-0022", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-580 TYLOVET 100 plus SACOX\nTylosin phosphate plus Salinomycin sodium Type A Medicated Articles For Use in the Manufacture of Type C Medicated Feeds Broiler Chickens", "Supporting & Related Material", "Background Material", "2015-09-04T04:00:00Z", 2015, 9, null, null, "2015-09-04T14:09:50Z", null, 0, 0, "0900006481c563a4"], ["FDA-2015-N-0002-0019", "FDA", "FDA-2015-N-0002", "Determination That BIAXIN XL Oral Tablets Were Not Withdrawn From Sale\nfor Reasons of Safety or Effectiveness", "Notice", "Determinations", "2015-08-27T04:00:00Z", 2015, 8, "2015-08-27T04:00:00Z", null, "2015-08-27T14:09:01Z", "2015-21236", 0, 0, "0900006481c3d449"], ["FDA-2015-N-0002-0018", "FDA", "FDA-2015-N-0002", "Determination That ABILIFY (Aripiprazole) Solution Was Not\nWithdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2015-06-23T04:00:00Z", 2015, 6, "2015-06-23T04:00:00Z", null, "2015-06-23T14:11:08Z", "2015-15327", 0, 0, "0900006481b4f384"], ["FDA-2015-N-0002-0011", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-557 Tiletamine-Zolazepam tiletamine HCl and zolazepam HCl Injectable solution\nDogs and cats", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:07:05Z", null, 0, 0, "0900006481b3e437"], ["FDA-2015-N-0002-0016", "FDA", "FDA-2015-N-0002", "FERTAGYL (gonadorelin) Sterile Solution", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:08:05Z", null, 0, 0, "0900006481b3e435"], ["FDA-2015-N-0002-0010", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Change of\nSponsor", "Rule", "Final Rule", "2015-06-16T04:00:00Z", 2015, 6, "2015-06-16T04:00:00Z", null, "2015-06-16T13:51:36Z", "2015-14734", 0, 0, "0900006481b3c152"], ["FDA-2015-N-0002-0014", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA 141-238 SPECTRAMAST LC Sterile Suspension\nCeftiofur Intramammary Suspension Cattle (lactating dairy)", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:07:28Z", null, 0, 0, "0900006481b3e43a"], ["FDA-2015-N-0002-0013", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-579 Altrenogest Solution\nAltrenogest Oral Solution Swine", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:07:22Z", null, 0, 0, "0900006481b3e439"], ["FDA-2015-N-0002-0012", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ORIGINAL ABBREVIATED NEW ANIMAL DRUG APPLICATION ANADA 200-578 Carprofen Flavored Tablets\nCarprofen Flavored Tablets Dogs", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:07:15Z", null, 0, 0, "0900006481b3e438"], ["FDA-2015-N-0002-0017", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY ANADA 200-134 FERTAGYL\nGonadorelin Sterile solution Lactating dairy cows", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:08:20Z", null, 0, 0, "0900006481b3e436"], ["FDA-2015-N-0002-0015", "FDA", "FDA-2015-N-0002", "Finding of No Significant Impact (FONSI) for FERTAGYL (gonadorelin acetate) For use with ESTRUMATE (cloprostenol injection) to synchronize estrous cycles to allow for fixed-time artificial insemination (FTAI) in\nLactating Dairy Cows", "Supporting & Related Material", "Background Material", "2015-06-16T04:00:00Z", 2015, 6, null, null, "2015-06-16T20:07:39Z", null, 0, 0, "0900006481b3e43b"], ["FDA-2015-N-0002-0009", "FDA", "FDA-2015-N-0002", "Withdrawal of Approval of New Animal Drug Application; Chlortetracycline", "Notice", "Withdrawal", "2015-06-04T04:00:00Z", 2015, 6, "2015-06-04T04:00:00Z", null, "2015-06-04T15:37:26Z", "2015-13633", 0, 0, "0900006481b1a331"], ["FDA-2015-N-0002-0003", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY NADA 141-435 ADVANTUS\nImidacloprid Chewable Tablet Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2015-04-08T04:00:00Z", 2015, 4, null, null, "2015-04-08T14:45:09Z", null, 0, 0, "0900006481a94545"], ["FDA-2015-N-0002-0004", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY - NADA 141-418 BETAVET Betamethasone sodium phosphate and betamethasone acetate\nInjectable Suspension Horses re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2015-04-08T04:00:00Z", 2015, 4, null, null, "2015-04-08T14:50:07Z", null, 0, 0, "0900006481a94011"], ["FDA-2015-N-0002-0008", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY - NADA 141-406 NEXGARD\nAfoxolaner Chewable Tablet Dogs re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2015-04-08T04:00:00Z", 2015, 4, null, null, "2015-04-08T14:50:57Z", null, 0, 0, "0900006481a94552"], ["FDA-2015-N-0002-0006", "FDA", "FDA-2015-N-0002", "Freedom of Information Summary ANADA 200-576 Gentamicin Sulfate Ophthalmic Solution (gentamicin sulfate) Ophthalmic Solution\nDogs and cats re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2015-04-08T04:00:00Z", 2015, 4, null, null, "2015-04-08T14:50:35Z", null, 0, 0, "0900006481a9400c"], ["FDA-2015-N-0002-0007", "FDA", "FDA-2015-N-0002", "FREEDOM OF INFORMATION SUMMARY - NADA 141-280 ZILMAX (zilpaterol hydrochloride) plus RUMENSIN (monensin) plus TYLAN (tylosin phosphate) plus MGA (melengestrol acetate) Type A medicated\narticles re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2015-04-08T04:00:00Z", 2015, 4, null, null, "2015-04-08T14:50:45Z", null, 0, 0, "0900006481a94551"], ["FDA-2015-N-0002-0002", "FDA", "FDA-2015-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Withdrawal\nof Approval of New Animal Drug Application; Fomepizole", "Rule", "Withdrawal", "2015-04-08T04:00:00Z", 2015, 4, "2015-04-08T04:00:00Z", null, "2015-04-08T14:01:00Z", "2015-08024", 0, 0, "0900006481a9424e"], ["FDA-2015-N-0002-0001", "FDA", "FDA-2015-N-0002", "New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Rule", "Final Rule", "2015-04-08T04:00:00Z", 2015, 4, "2015-04-08T04:00:00Z", null, "2015-04-08T13:56:23Z", "2015-08025", 0, 0, "0900006481a9424b"], ["FDA-2015-N-0002-0005", "FDA", "FDA-2015-N-0002", "Freedom of Information Summary - ANADA 200-527 Enrofloxacin Antibacterial Injectable Solution re New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor\u2019s Name; Change of Sponsor\u2019s Address", "Supporting & Related Material", "Background Material", "2015-04-08T04:00:00Z", 2015, 4, null, null, "2015-04-08T14:50:22Z", null, 0, 0, "0900006481a93fcb"]], "truncated": false, "filtered_table_rows_count": 70, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2015-N-0002"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002", "results": [{"value": "FDA", "label": "FDA", "count": 70, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2015-N-0002", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 51, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&document_type=Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002", "results": [{"value": 2015, "label": 2015, "count": 59, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&posted_year=2015", "selected": false}, {"value": 2016, "label": 2016, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&posted_year=2016", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2015-N-0002&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 557.9319720854983, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}